Edoardo Cignoli
giovedì 29 gennaio 2015
Edoardo Cignoli : Alexion Pharmaceuticals Names COO to CEO
Alexion Pharmaceuticals Inc. said Thursday that its No. 2 executive would take over as chief executive of the rare-disease drug developer.
via WSJ.com: US Business http://ift.tt/1wFELAk
Nessun commento:
Posta un commento
‹
›
Home page
Visualizza versione web
Nessun commento:
Posta un commento